Reference priceEUR €4.84Original source price: INR 440.00. Converted estimates are available by currency selection.
| Brand | Legalon Protect Madaus |
|---|---|
| Manufacturer | Meda Pharma GmbH & Co. KG |
| Prescription required | Yes |
Legalon Protect Madaus 54.1mg(Silymarin)
Silymarin
Description
Legalon Protect Madaus 54.1mg(Silymarin) is a medicine catalog record in the MediPriceHub database. Active ingredient: Silymarin. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Meda Pharma GmbH & Co. KG. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Hepatoprotect. Pack information: 54.1 / 100. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
Silymarin is a milk thistle extract used in some countries as supportive treatment for liver disorders. It is generally positioned as hepatoprotective support rather than a substitute for disease-specific antiviral or liver-directed therapy.How to Use
Legalon Protect Madaus Meda Pharma GmbH & Co. KG = Silymarin 54,1mg Schwangerschaft SonstigesSpecification
Active ingredient: Silymarin. Pack size: 54.1 / 100. Pack unit: box. Manufacturer: Meda Pharma GmbH & Co. KG. Origin country: Germany. Source category: Medicine Library > Liver and Gallbladder Diseases > Hepatoprotect. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Possible adverse effects vary by active ingredient, dose, route, treatment duration, and patient condition. Common issues may include gastrointestinal symptoms, headache, dizziness, fatigue, rash, allergic reactions, or abnormal laboratory tests. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.